
GRAIL’s Moves with MCED Test Illustrate Direct-to-Consumer Surge
By partnering with Hims & Hers and Epic, GRAIL bypasses traditional lab test arrangement

By partnering with Hims & Hers and Epic, GRAIL bypasses traditional lab test arrangement

The intent of the at-home testing is to identify and treat issues such as postpartum depression and vitamin deficiencies

Teal Health, the company manufacturing and distributing the test, says thousands of women are already on a waiting list for the assay

The 15-minute assay to detect sepsis and assess its severity and risk is expected to get full FDA approval by 2026

On-demand testing doesn’t require registration, billing, or scheduling, keeping costs low while collecting “real” dollars upfront